Companies: 10,795·Total market cap: $144.5T
Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.

PRTKNASDAQHealthcare
$2.23
+$0.04(+1.83%)
Market Cap$127828952
P/E Ratio—
52W High$3.65
52W Low$1.29
SEC Filings

Paratek Pharmaceuticals, Inc. (PRTK) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001178711 · PRTK · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,010+
Total Filings
15-12G
Latest Form
2023-10-02
Most Recent
2009
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001178711 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-04-27
Fiscal Year End
Apr 27, 2023
Accession No.
0001628280-23-013599
Primary Document
prtk-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001178711 · Accession 0001628280-23-013599

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-03
View 10-Q on SEC
8-KCurrent Report
8-K
2023-09-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-10-02
View
EFFECTEFFECT
EFFECT
2023-09-25
View
SC 13E3/ASC 13E3/A
SC 13E3/A
2023-09-21
View
POS AMPOS AM
POS AM
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
S-8 POSS-8 POS
S-8 POS
2023-09-21
View
Showing 1–15 of 610 filingsForm 4 / 144 hidden· 1010 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001178711  |  Exchange: NASDAQ · Healthcare

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) has submitted 1,010+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001178711, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Paratek Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Paratek Pharmaceuticals, Inc. 10-K was filed on 2023-04-27 for fiscal year ending 2023. Historical PRTK 10-K annual reports are available from 2009 through 2023.

Investors researching Paratek Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TRML SEC Filings →SELB SEC Filings →PRDS SEC Filings →NGM SEC Filings →SESN SEC Filings →KNTE SEC Filings →DBTX SEC Filings →GRAY SEC Filings →
→ PRTK Financials→ PRTK Earnings→ PRTK Insider Trades

Frequently Asked Questions

PRTK SEC Filings · 8 questions

Paratek Pharmaceuticals, Inc. (PRTK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,010+ filings and access original documents at no cost. Paratek Pharmaceuticals, Inc.'s CIK is 0001178711.

PRTK SEC filingsParatek Pharmaceuticals, Inc. SEC documentsfind PRTK 10-K